We will certainly be doing much more of this over the coming months, but it is not as simple as just having a one minute pitch. It is not credible for me to say in a one minute pitch that we have a drug with a market potential greater than $15 billion per year that is worth between $50 and $80 billion. People just immediately ignore anything you have to say as it sounds ludicrous - that is until you have done a huge amount of research like most of you here and you then realise what an amazing drug bisantrene is.
The far bigger issue is not getting people interested in RAC, but giving them some good reason to buy now. This is where I need help*, because interest in RAC without buying interest is not going to change the SP.
*I am working on this problem and I have a few promising approaches underway.
RAC media coverage, page-1868
-
- There are more pages in this discussion • 397 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 8662 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |